YPrime

We specialize in eCOA (electronic Clinical Outcome Assessment), IRT (Interactive Response Technology), and eConsent solutions for clinical trials. These tools help improve participant compliance, streamline site workflows, and provide sponsors with dashboards for decision-making. Our eCOA platform uses AI-supported localization and pre-validated, configurable components to speed up global study startups. Our IRT platform supports complex trial designs and allows for quick protocol updates. Our eConsent solutions aim to simplify enrollment and help patients better understand trials. We also offer clinical trial consulting to optimize processes, align technology with regulations, integrate systems, and turn operational data into actionable insights.

Pharmaceutical companies, emerging biotechs, and Contract Research Organizations (CROs) use our technology in therapeutic areas like oncology, rare disease, CNS, cardiometabolic, vaccines, and ophthalmology. Founded in 2006, we have 201-500 employees. Our solutions are available in over 250 languages and supported in more than 100 countries. We have implemented about 1,000 studies globally and engaged over 125,000 patients, leveraging more than 16 years of eClinical experience. Our platforms can cut IRT and eCOA startup times by about 50%, and the eCOA platform is 100% configurable and no-code.

Our mission is to advance science and health by simplifying complex global clinical trials. We are committed to sustainability, demonstrated by our top-tier EcoVadis rating, which places us in the top 35% of companies globally for Environmental, Social, and Governance (ESG) performance. This means we enforce a Sustainable Procurement Policy, implement global device recycling programs, and are developing a carbon management plan aligned with the Paris Agreement targets.

We also prioritize ethical labor practices and inclusion. We foster a workplace where individuals feel respected, valued, and empowered, providing equal opportunities regardless of characteristics such as race, gender, age, religion, or disability. We partner with diverse suppliers and offer ongoing education and resources. We maintain a zero-tolerance policy for child labor, forced labor, and modern slavery, complying with applicable laws and regulations like the United Nations Guiding Principles on Business and Human Rights. Our practices include conducting due diligence, requiring suppliers to adhere to a Supplier Code of Conduct, and monitoring our supply chain to ensure compliance.

We take a “people first” approach, seeing each team member as an individual essential to our growth and success. Our culture emphasizes collaboration and a shared drive to create life-changing treatments for patients. Our leadership team brings experience from clinical operations, technology development, compliance, and commercialization.